Evidence map›Paper›PMID 32294302›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Novel role of dynamin-related-protein 1 in dynamics of ER-lipid droplets in adipose tissue.

Xin Li, Li Yang, Zhengmei Mao, Xueyang Pan, Yueshui Zhao, Xue Gu, Kristin Eckel-Mahan, Zhongyuan Zuo, Qiang Tong, Sean M Hartig and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Xin LiCenter for Metabolic and Degenerative Diseases, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.
Li YangCenter for Metabolic and Degenerative Diseases, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.
Zhengmei MaoMicroscopy Core, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.
Xueyang PanDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
Yueshui ZhaoCenter for Metabolic and Degenerative Diseases, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.
Xue GuCenter for Metabolic and Degenerative Diseases, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.
Kristin Eckel-MahanCenter for Metabolic and Degenerative Diseases, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.
Zhongyuan ZuoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Qiang TongChildren's Nutrition Research Center, Baylor College of Medicine, Houston, TX, USA.
Sean M HartigDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Xiaodong ChengDepartment of Integrative Biology and Pharmacology, Graduate Program in Cell and Regulatory Biology, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
Guangwei DuDepartment of Integrative Biology and Pharmacology, Graduate Program in Cell and Regulatory Biology, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
David D MooreDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Hugo J BellenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Hiromi SesakiDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kai SunCenter for Metabolic and Degenerative Diseases, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.
Brown Foundation · USThe University of Texas Health Science Center at Houston · USBaylor College of Medicine · USChildren's Nutrition Research Center at Baylor College of Medicine · USHoward Hughes Medical Institute · USJohns Hopkins University · USTexas Children's Hospital · USUniversity of Minnesota · US

Funding

METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITYR01DK114356 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2017 to 2025
$4.6M
Dichotomous Effects of MT1-MMP on Adipose Tissue RemodelingR01DK109001 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SUN, KAI · 2017 to 2021
$2.0M
Origins of Diet-Induced Circadian Reprogramming and PlasticityR01DK114037 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MAHAN, KRISTIN ECKEL · 2018 to 2022
$1.9M
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and TherapeuticsR35GM122536 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHENG, XIAODONG · 2017 to 2021
$1.9M
A critical role for PLD1 in osteoclast fusionR01AR075830 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DU, GUANGWEI · 2019 to 2023
$1.7M
Structure-based design of camel-like human selective mAbs against MMPs in diseaseR01GM115672 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI GE, XIN · 2016 to 2020
$1.5M
Mitochondrial Quality Control by Drp1R01GM123266 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SESAKI, HIROMI · 2018 to 2021
$1.4M
Regulation of Mitochondrial Division by Phosphatidic AcidR01GM130695 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SESAKI, HIROMI · 2019 to 2021
$933k
NIAMS NIH HHS R01 AR075830NIDDK NIH HHS R01 DK109001NIDDK NIH HHS R01 DK114037NIDDK NIH HHS R01 DK114356NIGMS NIH HHS R01 GM115672NIGMS NIH HHS R01 GM123266NIGMS NIH HHS R01 GM130695NIGMS NIH HHS R35 GM122536
6 · The paper itself

Abstract

Dynamin-Related-Protein 1 (DRP1) critically regulates mitochondrial and peroxisomal fission in multicellular organisms. However, the impact of DRP1 on other organelles, especially its direct influence on ER functions remains largely unclear. Here, we report that DRP1 translocates to endoplasmic reticulum (ER) in response to β-adrenergic stimulation. To further investigate the function of DRP1 on ER-lipid droplet (LD) dynamics and the metabolic subsequences, we generated an adipose tissue-specific DRP1 knockout model (Adipo-Drp1

Indexed as

3T3 CellsAdipocytesAdipose TissueAnimalsAutophagyCell LineDynaminsEndoplasmic ReticulumHEK293 CellsHumansLipid DropletsLipid MetabolismMaleMiceMitochondriaMitochondrial DynamicsDNM1L protein, humanDynaminsMitochondrial Proteinsenergy expenditureER retentionLD buddingLD morphologylipolysis

Identifiers

PMID32294302
PMCPMC7336545
OpenAlexW3015656417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.